Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • idonaldson
    Member
    • Oct 2009
    • 37

    #1

    How to interpret VCF quality scores?

    In [variant call format (VCF)][1] files produced at the end of the samtools mpileup variant detection [pipeline][2] there are two quality scores:

    1) QUAL (col 6) = Phred based score that the variant shown in the ALT col is wrong.

    2) INFO (col 8) MQ flag = RMA mapping quality

    The two scores do not have a linear relationship. Some variants have a high mapping quality, but lower QUAL....

    Can anyone describe how these two scores are created and how they are related?

    I want to be able to filter variants based on these two scores, but do not fully understand what they mean. Should i filter based on both scores or just 'QUAL' for variants?

    Thanks.


    [1]: http://www.1000genomes.org/wiki/Anal...mat-version-41
    [2]: http://samtools.sourceforge.net/mpileup.shtml
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    I've been wondering that myself, and we've taken a stab at doing some sanger sequencing to see what quality values are associated with getting positive sanger confirmation.

    But you are comparing apples and oranges here, I think. Mapping quality is about how likely it is that the read has mapped to the right place, and this has as much to do with your underlying genome as it does with the individual letter quality of the reads. So they shouldn't correlate much.

    There is, however, another quality score, the GQ. My ad hoc observations suggest that the GQ is less sensitive to depth of coverage than the quality score, and this makes it less useful for determine which SNPs are real than the QUAL score.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...